22 results
424B4
CGTX
Cognition Therapeutics, Inc.
14 Nov 22
Prospectus supplement with pricing info
6:02am
” and a “smaller reporting company” and, as a result of the reduced disclosure and governance requirements applicable to emerging growth companies … and regulations regarding corporate governance practices. The listing requirements of the Nasdaq Global Market and the rules of the SEC require that we
DRS
6uju7xow9va l33yuqp7
20 Oct 22
Draft registration statement
12:00am
DEF 14A
9khvnrf 2genryinvjc
25 Apr 22
Definitive proxy
5:28pm
10-K
abfbm0
30 Mar 22
Annual report
7:40am
10-Q
jk4h3w55nqvogunja
17 Nov 21
Quarterly report
5:15pm
8-K
emc k2yhl02f
3 Nov 21
Departure of Directors or Certain Officers
4:25pm
8-K
EX-3.2
4o34flh6r
14 Oct 21
Amendments to Articles of Incorporation or Bylaws
4:41pm
424B4
nm56br
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
9hgzd r5hqgmbdxpe
19 Jul 21
IPO registration
7:02am